After integration of the batches, 1,425 cells passed the quality assessment, of which 148 and 737 were tdTomato+PDGFRβ+ from the healthy and ischemic muscles (day 21 after ischemia), respectively, whereas 177 and 363 were tdTomato−PDGFRβ+ (Fig. 2b,c). This evidence concerns the gene PDGFRB and ischemia.